Amgen Inc (NASDAQ:AMGN)

171.56
Delayed Data
As of Apr 20
 -1.37 / -0.79%
Today’s Change
152.16
Today|||52-Week Range
201.23
-1.35%
Year-to-Date

Today’s Trading

Previous close172.93
Today’s open173.10
Day’s range170.57 - 173.47
Volume2,958,550
Average volume (3 months)4,439,282
Market cap$137.7B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-73.73%
Earnings growth (this year)+6.60%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+0.45%
P/E ratio63.8
Price/Sales5.61
Price/Book5.47

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.74-0.99%
BIIBBiogen-3.00-1.13%
ILMNIllumina Inc-1.24-0.50%
----
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateApril 25, 2018
EPS forecast (this quarter)$3.20
Annual revenue (last year)$22.8B
Annual profit (last year)$2.0B
Net profit margin8.69%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts